Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience (TWST)
NASDAQ:TWST
TWST Stock Chart & Stats
$41.41
-$0.78(-1.71%)
At close: 4:00 PM EST
$41.41
-$0.78(-1.71%)
Day’s Range― - ―
52-Week Range$23.30 - $55.33
Previous CloseN/A
Volume152.02K
Average Volume (3M)1.14M
Market Cap
$2.53B
Enterprise Value$1.54B
Total Cash (Recent Filing)$232.43M
Total Debt (Recent Filing)$75.57M
Price to Earnings (P/E)―
Beta2.07
Next Earnings
Feb 02, 2026EPS Estimate
-0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding61,273,650
10 Day Avg. Volume1,403,675
30 Day Avg. Volume1,138,967
Financial Highlights & Ratios
PEG Ratio0.34
Price to Book (P/B)3.56
Price to Sales (P/S)4.47
P/FCF Ratio-22.25
Enterprise Value/Market Cap0.61
Enterprise Value/Revenue4.10
Enterprise Value/Gross Profit8.08
Enterprise Value/Ebitda-29.57
Forecast
1Y Price Target
$41.25Price Target Upside-0.39% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-1.49
Revenue Forecast (FY)$431.24M
Bulls Say, Bears Say
Bulls Say
Proprietary Technology AdvantageProprietary silicon-chip DNA synthesis technology provides cost, speed, and scale advantages that can increase throughput and strengthen market share in sequencing and synthetic biology applications.
Revenue MomentumManagement issued a revenue preannouncement and reported preliminary results above analyst consensus, signaling constructive momentum that could restore investor confidence.
Valuation And Profitability PathShares trade at a discount to high-growth life-science peers while management's timeline to reach adjusted EBITDA breakeven in the fourth quarter of 2026 outlines a clear path toward improved profitability.
Bears Say
Customer Concentration RiskA significant transition with a large oncology diagnostics customer created a meaningful headwind that underscores customer concentration and execution risks.
Guidance Shortfall And Margin PressureCompany guidance for 2026 revenue and gross margin came in below analyst expectations, raising concerns about near-term growth and profitability assumptions.
NGS Growth DecelerationA sequential decline in NGS revenues and lower NGS growth assumptions embedded in guidance suggest potential weakening in a key growth driver for the business.
Twist Bioscience News
TWST FAQ
What was Twist Bioscience’s price range in the past 12 months?
Twist Bioscience lowest stock price was $23.30 and its highest was $55.33 in the past 12 months.
What is Twist Bioscience’s market cap?
Twist Bioscience’s market cap is $2.53B.
When is Twist Bioscience’s upcoming earnings report date?
Twist Bioscience’s upcoming earnings report date is Feb 02, 2026 which is in 15 days.
How were Twist Bioscience’s earnings last quarter?
Twist Bioscience released its earnings results on Nov 14, 2025. The company reported -$0.45 earnings per share for the quarter, missing the consensus estimate of -$0.415 by -$0.035.
Is Twist Bioscience overvalued?
According to Wall Street analysts Twist Bioscience’s price is currently Overvalued.
Does Twist Bioscience pay dividends?
Twist Bioscience does not currently pay dividends.
What is Twist Bioscience’s EPS estimate?
Twist Bioscience’s EPS estimate is -0.43.
How many shares outstanding does Twist Bioscience have?
Twist Bioscience has 61,273,650 shares outstanding.
What happened to Twist Bioscience’s price movement after its last earnings report?
Twist Bioscience reported an EPS of -$0.45 in its last earnings report, missing expectations of -$0.415. Following the earnings report the stock price went down -10.134%.
Which hedge fund is a major shareholder of Twist Bioscience?
Currently, no hedge funds are holding shares in TWST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Twist Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$41.25 (-0.39% Downside)
$41.25 (-0.39% Downside)
Blogger Sentiment
Neutral
TWST Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $174.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.72%
12-Months-Change
Fundamentals
Return on Equity
-16.43%
Trailing 12-Months
Asset Growth
4.48%
Trailing 12-Months
Company Description
Twist Bioscience
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
TWST Company Deck
TWST Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Twist Bioscience reported strong financial performance with record revenue and significant margin improvement, driven by growth in SynBio, Biopharma, and NGS segments. However, the transition of a major customer and moderate growth guidance for fiscal 2026 presents challenges. The company is optimistic about future growth driven by AI-enabled discovery and new product introductions.View all TWST earnings summariesTWST Stock 12 Month Forecast
Average Price Target
$41.25
▼(-0.39% Downside)
Technical Analysis
Ownership Overview
Currently, No data available
---